High-Level Overview
New Incentives is a nonprofit organization that operates a conditional cash transfer (CCT) program in northern Nigeria to increase routine childhood vaccination rates. By providing small cash incentives to caregivers when their children receive vaccinations, New Incentives addresses the critical public health problem of low immunization coverage in regions with high child mortality from vaccine-preventable diseases. Their program is recognized as highly cost-effective, with estimates suggesting it costs between $1,500 and $6,000 to avert a child death in their target areas. This approach not only raises vaccination rates but also strengthens vaccine supply chains and public awareness, thereby saving lives and improving health outcomes in underserved communities[1][2][5].
For an investment firm, New Incentives exemplifies a mission-driven organization focused on evidence-based interventions that deliver measurable social impact. Their investment philosophy centers on cost-effectiveness and rigorous data monitoring to maximize lives saved per dollar spent. Key sectors include global health, social impact, and development economics, particularly in low-resource settings. Their impact on the startup ecosystem is indirect but significant, as they demonstrate how data-driven, scalable social programs can attract philanthropic and impact investment capital, influencing how health interventions are designed and funded.
For a portfolio company perspective, New Incentives builds a conditional cash transfer platform that serves caregivers of young children in northern Nigeria, incentivizing vaccination adherence. The problem they solve is the low vaccination coverage and associated high child mortality due to preventable diseases. Their growth momentum is strong, with operations in nine Nigerian states, millions of cash disbursements made, and plans to expand to reach millions more infants by 2025, supported by robust randomized controlled trial evidence and endorsements from top evaluators like GiveWell[3][5][6].
---
Origin Story
New Incentives was founded in 2011 by Svetha Janumpalli, Patrick Stadler, and Pratyush Agarwal. The founders were inspired by research on conditional cash transfers as a powerful, evidence-based tool for improving health outcomes. Initially, the organization focused on preventing mother-to-child transmission of HIV through CCTs, piloting programs in Nigeria and gaining early traction by presenting at the 2012 Clinton Global Initiative. Over time, they pivoted to focus on childhood immunization, recognizing the broader impact potential. The organization joined Y Combinator, which helped scale operations and bring on co-founders Stadler and Agarwal. Their evolution reflects a data-driven approach, expanding from HIV prevention to broader vaccination efforts across multiple Nigerian states[3][4][2].
---
Core Differentiators
- Evidence-Based Model: Uses conditional cash transfers proven by randomized controlled trials to effectively increase vaccination rates.
- Cost-Effectiveness: Among the most cost-effective global health interventions, with rigorous monitoring to ensure funds reach intended beneficiaries.
- Fraud Prevention: Implements comprehensive fraud detection and prevention systems, including payment verification and unannounced audits.
- Integrated Approach: Combines cash incentives with vaccine supply chain improvements and public awareness campaigns.
- Local Presence: Operates through a Nigerian local entity (All Babies Are Equal Initiative) with thousands of employees and presence in thousands of clinics.
- Data-Driven Operations: Continuously refines program design and delivery based on real-time data and impact evaluations.
- Strong Endorsements: Recognized by GiveWell as a top charity and recommended by other impact evaluators for its transparency and impact[1][2][4][5].
---
Role in the Broader Tech Landscape
New Incentives rides the global trend toward leveraging behavioral economics and digital tools to improve health outcomes in low-resource settings. The timing is critical as Nigeria and similar countries face persistent challenges with vaccine-preventable diseases amid growing digital infrastructure and data availability. Market forces such as increased donor interest in measurable impact and scalable health innovations favor New Incentives’ model. By demonstrating how conditional cash transfers can be effectively implemented at scale with robust data systems, New Incentives influences the broader ecosystem of global health tech and social impact investing, encouraging more evidence-based, tech-enabled interventions[1][5][7].
---
Quick Take & Future Outlook
Looking ahead, New Incentives aims to expand its reach to millions more infants by 2025, requiring substantial funding but promising significant lives saved. Trends shaping their journey include increasing digital payment infrastructure in Africa, growing donor emphasis on cost-effectiveness, and advances in data analytics for program monitoring. Their influence may evolve beyond Nigeria as their model could be adapted to other countries facing similar vaccination challenges. Continued innovation in fraud prevention and integration with government health systems will be key to sustaining and scaling impact. New Incentives exemplifies how targeted cash incentives, combined with data-driven program management, can transform public health outcomes in challenging environments[5][7].
This positions New Incentives not only as a life-saving program but also as a pioneering example of how technology and behavioral economics can be harnessed to solve entrenched global health problems efficiently and transparently.
